Product image of Ninur (Nitrofurantoin) supplied by GNH India

Ninur

Active Ingredient:
Nitrofurantoin
Origin:
EU

Ninur (Nitrofurantoin)

Nitrofurantoin, the active ingredient in Ninur, is a nitrofuran antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria, primarily in adult patients.

GNH India supplies Ninur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products and reliable logistics for global healthcare providers. The product complies with European Union pharmacopeial standards and is manufactured under GMP conditions. It is distributed through GNH India's established network to meet the needs of diverse markets.

Manufacturer / TM Owner

Belupo D.D.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nitrofurantoin is used primarily for infections of the urinary tract caused by susceptible bacteria.

  • Uncomplicated urinary tract infection: eradicates the causative bacteria and resolves dysuria, frequency and urgency.
  • Acute cystitis: provides rapid symptom relief and bacterial clearance in adult women.
  • Recurrent urinary tract infection prophylaxis: reduces the frequency of new infections when administered over a prolonged period.

How It Works

  • Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that damage bacterial DNA, ribosomal proteins and enzymes involved in carbohydrate metabolism. This multi‑targeted attack disrupts essential cellular processes, leading to bacterial cell death while sparing most human cells due to limited drug activation in mammalian tissues.

Side Effects

Adverse reactions may occur with nitrofurantoin therapy and vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Loss of appetite: reduced desire to eat.
  • Headache: transient cranial discomfort.
  • Diarrhea: loose stools, usually self‑limiting.
  • Metallic taste: transient alteration of taste perception.
  • Mild skin rash: localized erythema or itching.

Serious or Rare Side Effects

  • Pulmonary toxicity: interstitial pneumonitis or fibrosis, potentially life‑threatening.
  • Hepatic injury: jaundice, elevated liver enzymes.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Hemolytic anemia: especially in patients with G6PD deficiency.
  • Peripheral neuropathy: numbness or tingling in extremities.
  • Agranulocytosis: marked reduction in white blood cells.

Precautions & Warnings

Before initiating nitrofurantoin, clinicians should consider several safety aspects.

  • Renal function assessment: avoid use in patients with creatinine clearance <60 mL/min.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • G6PD deficiency: contraindicated due to risk of hemolysis.
  • Long‑term therapy: monitor for pulmonary or hepatic toxicity.
  • Concomitant nephrotoxic drugs: exercise caution to prevent renal impairment.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nitrofurantoin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption.
  • Probenecid: increases nitrofurantoin plasma concentrations, raising toxicity risk.
  • Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
  • Methenamine: concurrent use can diminish antimicrobial activity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: combined renal stress may impair kidney function.
  • Diuretics: altered urinary concentration can affect drug excretion.
  • Fluoroquinolones: concurrent use may increase risk of tendon disorders.

Frequently Asked Questions

Ninur contains nitrofurantoin, an antibiotic indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria, and it can also be used for prophylaxis of recurrent infections when prescribed by a qualified healthcare professional.

Nitrofurantoin is reduced inside bacterial cells to reactive intermediates that damage DNA, ribosomal proteins and enzymes involved in carbohydrate metabolism, leading to bacterial cell death while having limited activity in human cells.

The dosage of Ninur is determined by the prescribing clinician based on the patient’s condition, renal function and local treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional.

Safety of nitrofurantoin in pregnancy and lactation depends on the trimester and individual risk factors. It should only be used when the potential benefit justifies any possible risk, and the decision must be made by the treating physician.

To request Ninur, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ninur (nitrofurantoin) is a nitrofuran antibiotic that concentrates in urine, offering targeted activity against common uropathogens. Compared with trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin has a lower risk of promoting resistance but is contraindicated in patients with reduced renal function.

Ninur tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Ninur is taken orally, usually with a full glass of water. It may be taken with food or on an empty stomach, depending on the prescriber’s instructions, to improve tolerability and absorption.

Serious adverse events include pulmonary toxicity (interstitial pneumonitis or fibrosis), hepatic injury, severe allergic reactions such as anaphylaxis, hemolytic anemia in patients with G6PD deficiency, peripheral neuropathy and agranulocytosis. Prompt medical attention is required if any of these occur.

Ninur should be avoided in patients with severe renal impairment (creatinine clearance <60 mL/min), known hypersensitivity to nitrofurantoin, G6PD deficiency, or in those who are pregnant in the first trimester unless the benefits outweigh the risks. Clinicians should assess each patient individually.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.